Literature DB >> 31971616

Closure of the fascial defect during laparoscopic umbilical hernia repair: a randomized clinical trial.

M W Christoffersen1, M Westen1, J Rosenberg2, F Helgstrand3, T Bisgaard1.   

Abstract

BACKGROUND: The objective of the study was to analyse patient-reported outcome measures (PROMs), seroma formation, long-term recurrence and chronic pain after closure of the fascial defect in patients undergoing laparoscopic umbilical hernia mesh repair.
METHODS: This was a randomized double-blinded trial in patients undergoing elective laparoscopic umbilical hernia repair comparing sutured closure of the fascial defect before intraperitoneal onlay mesh (IPOM) repair with a no-closure IPOM repair. Postoperative pain, movement limitations, discomfort and fatigue were registered before surgery and on postoperative days 1-3, 7 and 30. Seroma formation, quality of life and cosmesis were assessed at day 30, and at 2 years of follow-up. Recurrence (clinical and reoperation) and chronic pain were assessed after 2 years.
RESULTS: Eighty patients were randomized. Median defect sizes in closure and no-closure groups were 2·5 (range 1·5-4·0) and 2·5 (2·0-5·5) cm respectively (P = 0·895). There were no significant differences in early and late postoperative pain or in any other early or late PROMs, except for early fatigue which was higher in the closure group (P = 0·011). Seroma formation after 30 days was significantly reduced after closure (14 of 40; 35 (95 per cent c.i. 22 to 51) per cent) compared with no closure (22 of 38; 58 (42 to 72) per cent) (P = 0·043). Cumulative recurrence after 2 years was lower in the closure group: 5 of 36 (7 (3 to 17) per cent) versus 12 of 37 (19 (10 to 33) per cent) for no closure (P = 0·047).
CONCLUSION: Closure of the fascial defect in laparoscopic umbilical hernia IPOM repair significantly reduced early seroma formation and long-term recurrence without inducing side-effects such as pain, or other early or late PROMs. Registration number: NCT01962480 ( https://www.clinicaltrials.gov).
© 2020 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2020        PMID: 31971616     DOI: 10.1002/bjs.11490

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  6 in total

1.  Primary closure of the midline abdominal wall defect during laparoscopic ventral hernia repair: analysis of risk factors for failure and outcomes at 5 years follow-up.

Authors:  Julio Gómez-Menchero; Andrea Balla; Ana Fernández Carazo; Salvador Morales-Conde
Journal:  Surg Endosc       Date:  2022-06-21       Impact factor: 4.584

2.  Short-term complications after minimally invasive retromuscular ventral hernia repair: no need for preoperative weight loss or smoking cessation?

Authors:  J R Ekmann; M W Christoffersen; K K Jensen
Journal:  Hernia       Date:  2022-08-22       Impact factor: 2.920

3.  A prospective, multicenter trial of a long-term bioabsorbable mesh with Sepra technology in cohort of challenging laparoscopic ventral or incisional hernia repairs (ATLAS trial).

Authors:  William W Hope; Adel G El-Ghazzawy; Brad A Winterstein; Jeffrey A Blatnik; S Scott Davis; Jacob A Greenberg; Noel C Sanchez; Eric M Pauli; Daniel M Tseng; Karl A LeBlanc; Kurt E Roberts; Curtis E Bower; Eduardo Parra-Davila; J Scott Roth; Corey R Deeken; Eric F Smith
Journal:  Ann Med Surg (Lond)       Date:  2021-12-06

4.  Laparoscopic ventral and incisional hernia repair using intraperitoneal onlay mesh with peritoneal bridging.

Authors:  F Ali; G Sandblom; A Wikner; G Wallin
Journal:  Hernia       Date:  2021-09-24       Impact factor: 4.739

5.  Comparison of outcomes of laparoscopic hernioplasty with and without fascial repair (IPOM-Plus vs IPOM) for ventral hernia: A retrospective cohort study.

Authors:  Sunil Basukala; Ayush Tamang; Sushil Bahadur Rawal; Srijan Malla; Ujwal Bhusal; Subodh Dhakal; Shriya Sharma
Journal:  Ann Med Surg (Lond)       Date:  2022-08-01

6.  Peritoneal bridging versus fascial closure in laparoscopic intraperitoneal onlay ventral hernia mesh repair: a randomized clinical trial.

Authors:  F Ali; G Wallin; B Fathalla; G Sandblom
Journal:  BJS Open       Date:  2020-05-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.